Logo image of CGNX

COGNEX CORP (CGNX) Stock Fundamental Analysis

NASDAQ:CGNX - Nasdaq - US1924221039 - Common Stock - Currency: USD

32.78  -0.62 (-1.86%)

After market: 32.78 0 (0%)

Fundamental Rating

6

CGNX gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 124 industry peers in the Electronic Equipment, Instruments & Components industry. While CGNX has a great health rating, its profitability is only average at the moment. CGNX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CGNX had positive earnings in the past year.
In the past year CGNX had a positive cash flow from operations.
CGNX had positive earnings in each of the past 5 years.
CGNX had a positive operating cash flow in each of the past 5 years.
CGNX Yearly Net Income VS EBIT VS OCF VS FCFCGNX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

Looking at the Return On Assets, with a value of 5.33%, CGNX is in the better half of the industry, outperforming 72.50% of the companies in the same industry.
Looking at the Return On Equity, with a value of 7.00%, CGNX is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
The Return On Invested Capital of CGNX (5.19%) is better than 64.17% of its industry peers.
CGNX had an Average Return On Invested Capital over the past 3 years of 7.69%. This is in line with the industry average of 8.95%.
Industry RankSector Rank
ROA 5.33%
ROE 7%
ROIC 5.19%
ROA(3y)7.31%
ROA(5y)9.14%
ROE(3y)9.83%
ROE(5y)12.61%
ROIC(3y)7.69%
ROIC(5y)9.5%
CGNX Yearly ROA, ROE, ROICCGNX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

CGNX's Profit Margin of 11.61% is amongst the best of the industry. CGNX outperforms 85.00% of its industry peers.
CGNX's Profit Margin has declined in the last couple of years.
CGNX's Operating Margin of 12.58% is amongst the best of the industry. CGNX outperforms 85.00% of its industry peers.
In the last couple of years the Operating Margin of CGNX has declined.
With an excellent Gross Margin value of 68.43%, CGNX belongs to the best of the industry, outperforming 98.33% of the companies in the same industry.
In the last couple of years the Gross Margin of CGNX has declined.
Industry RankSector Rank
OM 12.58%
PM (TTM) 11.61%
GM 68.43%
OM growth 3Y-25.46%
OM growth 5Y-8.53%
PM growth 3Y-24.51%
PM growth 5Y-16.2%
GM growth 3Y-2.25%
GM growth 5Y-1.51%
CGNX Yearly Profit, Operating, Gross MarginsCGNX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CGNX is destroying value.
The number of shares outstanding for CGNX has been reduced compared to 1 year ago.
The number of shares outstanding for CGNX has been reduced compared to 5 years ago.
There is no outstanding debt for CGNX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CGNX Yearly Shares OutstandingCGNX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CGNX Yearly Total Debt VS Total AssetsCGNX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

CGNX has an Altman-Z score of 8.50. This indicates that CGNX is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 8.50, CGNX belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
CGNX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.5
ROIC/WACC0.57
WACC9.06%
CGNX Yearly LT Debt VS Equity VS FCFCGNX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

CGNX has a Current Ratio of 3.62. This indicates that CGNX is financially healthy and has no problem in meeting its short term obligations.
CGNX has a Current ratio of 3.62. This is in the better half of the industry: CGNX outperforms 68.33% of its industry peers.
CGNX has a Quick Ratio of 2.69. This indicates that CGNX is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of CGNX (2.69) is better than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 3.62
Quick Ratio 2.69
CGNX Yearly Current Assets VS Current LiabilitesCGNX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

CGNX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 2.78%.
The Earnings Per Share has been decreasing by -2.03% on average over the past years.
CGNX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.20%.
The Revenue has been growing slightly by 4.74% on average over the past years.
EPS 1Y (TTM)2.78%
EPS 3Y-20.81%
EPS 5Y-2.03%
EPS Q2Q%81.82%
Revenue 1Y (TTM)9.2%
Revenue growth 3Y-4.11%
Revenue growth 5Y4.74%
Sales Q2Q%16.79%

3.2 Future

Based on estimates for the next years, CGNX will show a very strong growth in Earnings Per Share. The EPS will grow by 25.99% on average per year.
The Revenue is expected to grow by 11.06% on average over the next years. This is quite good.
EPS Next Y22.67%
EPS Next 2Y27.73%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue Next Year9.57%
Revenue Next 2Y11.15%
Revenue Next 3Y10.64%
Revenue Next 5Y11.06%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CGNX Yearly Revenue VS EstimatesCGNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B
CGNX Yearly EPS VS EstimatesCGNX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 44.30 indicates a quite expensive valuation of CGNX.
CGNX's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 29.63, CGNX is valued a bit more expensive.
The Price/Forward Earnings ratio is 36.11, which means the current valuation is very expensive for CGNX.
CGNX's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.68. CGNX is valued rather expensively when compared to this.
Industry RankSector Rank
PE 44.3
Fwd PE 36.11
CGNX Price Earnings VS Forward Price EarningsCGNX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

CGNX's Enterprise Value to EBITDA ratio is in line with the industry average.
CGNX's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 41.95
EV/EBITDA 36.7
CGNX Per share dataCGNX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CGNX does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of CGNX may justify a higher PE ratio.
CGNX's earnings are expected to grow with 25.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.95
PEG (5Y)N/A
EPS Next 2Y27.73%
EPS Next 3Y25.99%

5

5. Dividend

5.1 Amount

With a yearly dividend of 0.95%, CGNX is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.92, CGNX pays a better dividend. On top of this CGNX pays more dividend than 86.67% of the companies listed in the same industry.
With a Dividend Yield of 0.95, CGNX pays less dividend than the S&P500 average, which is at 2.29.
Industry RankSector Rank
Dividend Yield 0.95%

5.2 History

On average, the dividend of CGNX grows each year by 8.39%, which is quite nice.
CGNX has paid a dividend for at least 10 years, which is a reliable track record.
CGNX has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)8.39%
Div Incr Years3
Div Non Decr Years3
CGNX Yearly Dividends per shareCGNX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

49.29% of the earnings are spent on dividend by CGNX. This is a bit on the high side, but may be sustainable.
CGNX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP49.29%
EPS Next 2Y27.73%
EPS Next 3Y25.99%
CGNX Yearly Income VS Free CF VS DividendCGNX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
CGNX Dividend Payout.CGNX Dividend Payout, showing the Payout Ratio.CGNX Dividend Payout.PayoutRetained Earnings

COGNEX CORP

NASDAQ:CGNX (2/21/2025, 8:08:11 PM)

After market: 32.78 0 (0%)

32.78

-0.62 (-1.86%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-12 2025-02-12/amc
Earnings (Next)04-30 2025-04-30/bmo
Inst Owners99.53%
Inst Owner Change1.38%
Ins Owners0.23%
Ins Owner Change0.06%
Market Cap5.62B
Analysts75.17
Price Target46.4 (41.55%)
Short Float %2.59%
Short Ratio3.43
Dividend
Industry RankSector Rank
Dividend Yield 0.95%
Yearly Dividend0.31
Dividend Growth(5Y)8.39%
DP49.29%
Div Incr Years3
Div Non Decr Years3
Ex-Date02-27 2025-02-27 (0.08)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.96%
Min EPS beat(2)3.88%
Max EPS beat(2)26.05%
EPS beat(4)4
Avg EPS beat(4)20.41%
Min EPS beat(4)3.88%
Max EPS beat(4)41.77%
EPS beat(8)8
Avg EPS beat(8)20.23%
EPS beat(12)10
Avg EPS beat(12)16.52%
EPS beat(16)12
Avg EPS beat(16)13.48%
Revenue beat(2)1
Avg Revenue beat(2)0.4%
Min Revenue beat(2)-1.24%
Max Revenue beat(2)2.05%
Revenue beat(4)2
Avg Revenue beat(4)0.38%
Min Revenue beat(4)-2.41%
Max Revenue beat(4)3.11%
Revenue beat(8)5
Avg Revenue beat(8)0.88%
Revenue beat(12)7
Avg Revenue beat(12)0.46%
Revenue beat(16)9
Avg Revenue beat(16)0.61%
PT rev (1m)-0.98%
PT rev (3m)-3.53%
EPS NQ rev (1m)0.78%
EPS NQ rev (3m)0.78%
EPS NY rev (1m)-3.02%
EPS NY rev (3m)-3.66%
Revenue NQ rev (1m)-0.11%
Revenue NQ rev (3m)-0.11%
Revenue NY rev (1m)-0.39%
Revenue NY rev (3m)-0.87%
Valuation
Industry RankSector Rank
PE 44.3
Fwd PE 36.11
P/S 6.15
P/FCF 41.95
P/OCF 37.71
P/B 3.71
P/tB 5.4
EV/EBITDA 36.7
EPS(TTM)0.74
EY2.26%
EPS(NY)0.91
Fwd EY2.77%
FCF(TTM)0.78
FCFY2.38%
OCF(TTM)0.87
OCFY2.65%
SpS5.33
BVpS8.85
TBVpS6.07
PEG (NY)1.95
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.33%
ROE 7%
ROCE 6.31%
ROIC 5.19%
ROICexc 6%
ROICexgc 8.58%
OM 12.58%
PM (TTM) 11.61%
GM 68.43%
FCFM 14.66%
ROA(3y)7.31%
ROA(5y)9.14%
ROE(3y)9.83%
ROE(5y)12.61%
ROIC(3y)7.69%
ROIC(5y)9.5%
ROICexc(3y)9.56%
ROICexc(5y)11.82%
ROICexgc(3y)12.73%
ROICexgc(5y)15.09%
ROCE(3y)9.35%
ROCE(5y)11.55%
ROICexcg growth 3Y-25.69%
ROICexcg growth 5Y-4.75%
ROICexc growth 3Y-29.85%
ROICexc growth 5Y-7.09%
OM growth 3Y-25.46%
OM growth 5Y-8.53%
PM growth 3Y-24.51%
PM growth 5Y-16.2%
GM growth 3Y-2.25%
GM growth 5Y-1.51%
F-Score6
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 46.02%
Cap/Sales 1.64%
Interest Coverage 250
Cash Conversion 100.9%
Profit Quality 126.25%
Current Ratio 3.62
Quick Ratio 2.69
Altman-Z 8.5
F-Score6
WACC9.06%
ROIC/WACC0.57
Cap/Depr(3y)84%
Cap/Depr(5y)75.71%
Cap/Sales(3y)2.12%
Cap/Sales(5y)1.9%
Profit Quality(3y)103.13%
Profit Quality(5y)109.22%
High Growth Momentum
Growth
EPS 1Y (TTM)2.78%
EPS 3Y-20.81%
EPS 5Y-2.03%
EPS Q2Q%81.82%
EPS Next Y22.67%
EPS Next 2Y27.73%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue 1Y (TTM)9.2%
Revenue growth 3Y-4.11%
Revenue growth 5Y4.74%
Sales Q2Q%16.79%
Revenue Next Year9.57%
Revenue Next 2Y11.15%
Revenue Next 3Y10.64%
Revenue Next 5Y11.06%
EBIT growth 1Y-6.21%
EBIT growth 3Y-28.52%
EBIT growth 5Y-4.2%
EBIT Next Year67.2%
EBIT Next 3Y41.49%
EBIT Next 5Y34.84%
FCF growth 1Y49.2%
FCF growth 3Y-23.43%
FCF growth 5Y-10.36%
OCF growth 1Y32.03%
OCF growth 3Y-22%
OCF growth 5Y-10.06%